We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Allergan on Thursday revealed that it expects "mid-single-digit" revenue growth this year, led by new product launches, international growth and the performance of key products.